Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
M Ida, A Nishida, H Akiho, Y Nakashima… - BioPsychoSocial …, 2017 - Springer
Background Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3
receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) …
receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) …
Emerging drug for diarrhea predominant irritable bowel syndrome
S Deiana, T Gabbani, S Bagnoli… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal
disorders with a 9–23% prevalence estimated in the general population. Patients can be …
disorders with a 9–23% prevalence estimated in the general population. Patients can be …
Randomized controlled clinical study on effect of Chinese compound changjitai in treating diarrheic irritable bowel syndrome
Y Shen, G Cai, X Sun - Zhongguo Zhong xi yi jie he za zhi Zhongguo …, 2003 - europepmc.org
To verify the clinical efficacy and safety of the proven Chinese Compound Changjitai (CJT),
in treating the diarrheic irritable bowel syndrome (DIBS). Randomized controlled open …
in treating the diarrheic irritable bowel syndrome (DIBS). Randomized controlled open …
[HTML][HTML] Effectiveness of tong-xie-yao-fang combined with Si-Ni-san for irritable bowel syndrome: A protocol for systematic review and meta-analysis
J Jiang, Y Chen, Z Hu, H Li, J Ye, Z Yu, H Tang - Medicine, 2021 - journals.lww.com
Background: Irritable bowel syndrome (IBS) has a high morbidity rate worldwide, but there
are no effective treatment measures, which seriously affect people's lives. Previous clinical …
are no effective treatment measures, which seriously affect people's lives. Previous clinical …
The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
YS Shih, CH Tsai, TC Li, HC Lai, KT Wang… - Journal of …, 2019 - Elsevier
Background Irritable bowel syndrome (IBS) is characterized by chronic, recurrent abdominal
pain or abdominal discomfort and changes in defecation habits. Xiang-Sha-Liu-Jun-Zi tang …
pain or abdominal discomfort and changes in defecation habits. Xiang-Sha-Liu-Jun-Zi tang …
[HTML][HTML] Chinese herbal medicine versus probiotics for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
FL Bu, RL Chen, ZY Lin, HJ Cao, N Robinson… - European Journal of …, 2020 - Elsevier
Introduction Chinese herbal medicine (CHM) and probiotics are two complementary and
alternative approaches often used for irritable bowel syndrome (IBS). This study evaluates …
alternative approaches often used for irritable bowel syndrome (IBS). This study evaluates …
Current and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome
Introduction: Irritable bowel syndrome with diarrhea (IBS-D) is among the most common
functional gastrointestinal (GI) disorders and is associated with impaired quality of life …
functional gastrointestinal (GI) disorders and is associated with impaired quality of life …
Acupuncture for diarrhea-predominant irritable bowel syndrome: a meta-analysis
D Deng, K Guo, J Tan, G Huang, S Li… - Zhongguo Zhen jiu …, 2017 - europepmc.org
Objective To systematically evaluate the efficacy and safety of acupuncture on diarrhea-
predominant irritable bowel syndrome (IBS) in the past five years. Methods Online …
predominant irritable bowel syndrome (IBS) in the past five years. Methods Online …
Efficacy of integrated traditional Chinese medicine with Western medicine in patients with diarrhea-predominant irritable bowel syndrome and its relation to serum …
S Tang, M Cheng, Z WU, Y HU… - Chinese Journal of …, 2017 - pesquisa.bvsalud.org
Objective To investigate the efficacy of integrated traditional Chinese medicine (TCM) with
Western medicine in treatment of diarrhea type irritable bowel syndrome (IBS-D) and its …
Western medicine in treatment of diarrhea type irritable bowel syndrome (IBS-D) and its …
Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea
E Colomier, J Algera, C Melchior - Frontiers in Pharmacology, 2021 - frontiersin.org
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …